Target | cis/trans | Study | SNP | SNP location | Maj/min allele | MAF | N | βinv | seinv | Pinv | fclog | Plog | Praw |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IL-6 sRa | cis | Discovery | rs9427116 | 1:154,631,123 | C/T | 0.49 | 996 | -0.339 | 0.043 | 1.1×10-14 | -1.080 | 2.7×10-15 | 2.6×10-15 |
IL-6 sRa | cis | Replication | rs7547072 | 1:154,639,255 | G/A | 0.44 | 337 | 0.189 | 0.063 | 0.003 | 1.050 | 0.005 | 0.003 |
Target (abbrv.) | IL-6 sRa |
Target (full name) | Interleukin-6 receptor subunit alpha |
Somalogic ID (Sequence ID) | SL001943 (4139-71_2) |
Entrez Gene Symbol | IL6R |
UniProt ID | P08887 |
UniProt Comment |
|
Targeted by drugs (based on IPA annotation) |
|
Biomarker applications (based on IPA annotation) |
|
Wiki Pathways |
|
Pathway Interaction Database |
|
Reactome |
|
Pathway Studio |
|
All locus annotations are based on the sentinel SNP (rs9427116) and 10 proxy variant(s) that is/are in linkage disequilibrium r2 ≥ 0.8. Linkage disequilibrium is based on data from the 1000 Genomes Project, phase 3 version 5, European population and was retrieved using SNiPA's Block Annotation feature.
Download the detailed results of SNiPA's block annotation (PDF)
eQTL genes |
Trait | P | Study | Source |
---|---|---|---|
Gene expression of ADAR in blood | 1.1×10-6 | 21829388 (PMID) | GRASP2 eQTL |
Soluble IL6R (sIL6R) | 1.9×10-5 | 18464913 (PMID) | GRASP2 nonQTL |
Serum ratio of (7-methylxanthine)/(ursodeoxycholate) | 2.6×10-4 | 21886157 (PMID) | GRASP2 metabQTL |
Gene expression of SHE in blood | 4.8×10-4 | 21829388 (PMID) | GRASP2 eQTL |